Andrew Huberman: Focus, Controversy, Politics, and Relationships | Lex Fridman Podcast #435

Andrew Huberman tells Lex Fridman about his cannabis controversy, ibogaine interest, creative focus protocols, and plans to start a family.

• Huberman’s claim that high-THC cannabis can induce psychosis in certain individuals sparked a public academic attack on X, with the critic later agreeing to appear on the podcast.
• Cannabis has surpassed alcohol as the drug of choice in multiple US demographics, per coverage following the controversy.
• Stanford researcher Nolan Williams is studying ibogaine via TMS and brain imaging; ibogaine produces a 22-hour journey with eyes-closed replay of real life memories with user agency.
• Kentucky nearly redirected opioid settlement funds toward ibogaine research but backed away; $50 billion in opioid settlement money is flowing to states.
• BPC-157 peptide promotes angiogenesis in animal models, raising tumor vascularization concerns Huberman warns against continuous use despite its popularity.
• Huberman’s focus protocol: anatomical drawing (15 degrees off his main domain) primes deep work; targets 90-minute to 3-hour deep focus blocks, two to three per day.
• Huberman launched Sciyon Media with Rob Moore to scout and produce podcasts beyond Huberman Lab; first new show is Perform with Dr. Andy Galpin.

Guests: Andrew Huberman, Stanford neuroscientist and host of Huberman Lab Podcast · 2024-06-27 · Watch on YouTube